[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100054213":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":23,"locations":31,"responsibleParty":52,"collaborators":54,"id":58,"slug":59,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":62,"acronym":10,"eligibilityCriteria":63,"healthyVolunteers":60,"sex":64,"minAge":65,"maxAge":10,"enrollmentInfo":66,"targetDuration":10,"studyType":69,"phases":10,"briefSummary":70,"conditions":71,"keywords":10,"overallStatus":34,"whyStopped":10,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"Johns Hopkins University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Navio App",null,"The investigators propose to collect self-report and passively collected biological data and evaluate participants' relation to clinical and laboratory pain as well as patients' willingness to use and level of comfort with the mobile pain management digital platform and wearable biosensors. Eligible participants will be consented, given two biosensors (i.e., Apple Watch Series 1 with KardiaBand; Spire), a sleep monitoring device (actigraph watch), and a mobile app enabled smartphone, then trained on how to use the app (and device if appropriate) and biosensors. Participants will keep medications constant and not have any new pain treatment procedures over the course of the study period and 2 weeks prior to starting the study.",[13],"Other: Navio Mobile App",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Navio Mobile App","Participants will use the Navio Mobile App to track participants' pain and pain treatment",[9],[20],{"name":21,"affiliation":5,"role":22},"Luis F Buenaver, Ph. D","PRINCIPAL_INVESTIGATOR",[24,29],{"name":25,"role":26,"phone":27,"phoneExt":10,"email":28},"Luis F Buenaver, PhD","CONTACT","410-550-7000","lbuenav1@jhmi.edu",{"name":21,"role":26,"phone":30,"phoneExt":10,"email":28},"410-550-7986",[32],{"facility":33,"status":34,"city":35,"state":36,"zip":37,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"Behavioral Medicine Research Lab","RECRUITING","Baltimore","Maryland","21224","United States","US",{"type":41,"coordinates":42},"Point",[43,44],-76.61219,39.29038,{"lat":44,"lon":43},[47,50],{"name":48,"role":26,"phone":49,"phoneExt":10,"email":10},"Katie Dunnock","410-550-6165",{"name":51,"role":22,"phone":10,"phoneExt":10,"email":10},"Luis Buenaver, PhD",{"type":53,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[55],{"name":56,"class":57},"PainCare, LLC","UNKNOWN","100054213","using-technology-to-track-pain-and-pain-related-outcomes-100054213",false,"NCT04267588","Using Technology to Track Pain and Pain-related Outcomes","Inclusion Criteria:\n\n* ≥ 21 years of age\n* Pain duration \\> 3 months\n* Average pain level of \\>3 out of 10 (0=no pain; 10=worst pain imaginable)\n* English fluency\n* Are not scheduled to undergo any medical procedures during the course of the study\n* Have a physician-confirmed medical diagnosis associated with chronic pain\n* Are willing to comply with the study protocol and give written informed consent. Patients taking non-narcotic analgesics must be on a stable dose one month prior to participation.\n\nExclusion Criteria:\n\n* Delirium, dementia, or cognitive impairment (i.e., Mini Mental State Exam score \\\u003C24)\n* Unstable major psychiatric disorder or history of schizophrenia\n* Beck Depression Inventory score \\>30 or report of suicidal ideation\n* Active substance abuse;\n* Refusal to provide access to relevant medical record information.","ALL","21 Years",{"count":67,"type":68},100,"ESTIMATED","OBSERVATIONAL","Persistent pain is a public health epidemic. The current protocol seeks to develop technology to aid patients' tracking of patients' pain, medications and pain-related variables. The investigators seek to talk with patients in co-investigator's clinic to solicit feedback, as well as pilot test the technology with pain patients.",[72],"Pain, Chronic","2026-07-10",{"date":75,"type":76},"2026-07-13","ACTUAL",{"date":78,"type":76},"2020-08-10",{"date":80,"type":68},"2027-06-30",{"name":5,"class":6},1]